Avecho Biotechnology Ltd - Asset Resilience Ratio

Latest as of June 2025: 82.51%

Avecho Biotechnology Ltd (AVE) has an Asset Resilience Ratio of 82.51% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See AVE working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$5.93 Million

≈ $4.20 Million USD Cash + Short-term Investments

Total Assets

AU$7.19 Million

≈ $5.09 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (1993–2024)

This chart shows how Avecho Biotechnology Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Avecho Biotechnology Ltd's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Avecho Biotechnology Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read total liabilities of Avecho Biotechnology Ltd for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$5.93 Million	82.51%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$5.93 Million	82.51%

Asset Resilience Insights

Very High Liquidity: Avecho Biotechnology Ltd maintains exceptional liquid asset reserves at 82.51% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Avecho Biotechnology Ltd Industry Peers by Asset Resilience Ratio

Compare Avecho Biotechnology Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Avecho Biotechnology Ltd (1993–2024)

The table below shows the annual Asset Resilience Ratio data for Avecho Biotechnology Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	47.52%	AU$2.37 Million ≈ $1.68 Million	AU$5.00 Million ≈ $3.54 Million	+47.31pp
2023-12-31	0.21%	AU$15.73K ≈ $11.13K	AU$7.32 Million ≈ $5.18 Million	-46.23pp
2022-12-31	46.45%	AU$1.55 Million ≈ $1.10 Million	AU$3.35 Million ≈ $2.37 Million	-15.79pp
2021-12-31	62.23%	AU$3.26 Million ≈ $2.31 Million	AU$5.25 Million ≈ $3.71 Million	+6.41pp
2020-12-31	55.83%	AU$1.87 Million ≈ $1.33 Million	AU$3.35 Million ≈ $2.37 Million	-4.58pp
2019-12-31	60.40%	AU$3.21 Million ≈ $2.27 Million	AU$5.32 Million ≈ $3.76 Million	+15.26pp
2018-12-31	45.15%	AU$2.17 Million ≈ $1.53 Million	AU$4.80 Million ≈ $3.40 Million	+4.45pp
2017-12-31	40.70%	AU$3.35 Million ≈ $2.37 Million	AU$8.24 Million ≈ $5.83 Million	+39.16pp
2016-12-31	1.54%	AU$205.00K ≈ $145.05K	AU$13.35 Million ≈ $9.45 Million	+1.49pp
2003-12-31	0.05%	AU$13.78K ≈ $9.75K	AU$29.41 Million ≈ $20.81 Million	+0.05pp
2002-12-31	0.00%	AU$-429.00 ≈ $-303.54	AU$14.84 Million ≈ $10.50 Million	-1.31pp
2001-12-31	1.30%	AU$240.00K ≈ $169.82K	AU$18.40 Million ≈ $13.02 Million	-0.61pp
2000-12-31	1.92%	AU$400.00K ≈ $283.03K	AU$20.86 Million ≈ $14.76 Million	+1.34pp
1999-12-31	0.58%	AU$29.44K ≈ $20.83K	AU$5.10 Million ≈ $3.61 Million	+0.58pp
1996-12-31	0.00%	AU$-499.00 ≈ $-353.07	AU$33.01 Million ≈ $23.36 Million	-84.53pp
1993-12-31	84.53%	AU$10.04 Million ≈ $7.10 Million	AU$11.88 Million ≈ $8.40 Million	--

pp = percentage points

About Avecho Biotechnology Ltd

AU:AVE Australia Biotechnology

Market Cap

$54.68 Million

AU$77.27 Million AUD

Market Cap Rank

#21670 Global

#751 in Australia

Share Price

AU$0.02

Change (1 day)

-4.76%

52-Week Range

AU$0.01 - AU$0.03

All Time High

AU$0.04